Zhang Xinyi, Cai Yulong, Xiong Xianze, Liu Ao, Zhou Rongxin, You Zhen, Li Fuyu, Cheng Nansheng
Division of Biliary Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Intractable Rare Dis Res. 2022 Nov;11(4):161-172. doi: 10.5582/irdr.2022.01109.
As a consequence of breakthroughs in the area of guidelines research, the therapy for cholangiocarcinoma has significantly improved the efficacy rate of diagnosis and survival outcomes. We compared the most recently updated clinical practice guidelines and consensus to provide recommendations based on the diagnostic and therapeutic equipment available in various countries. Following a systematic review, we discovered that these guidelines and consensus had both similarities and differences in terms of what organizations or groups drafted the guidelines and the approach, applicability, content and recent updates of the guidelines as well as in terms of diagnostic and treatment algorithms. The disparities could be attributable to a variety of etiological factors, high risk patients, health resources, medical technology, treatment options, and income levels. Additionally, while complete adoption of guidelines may benefit physicians, patients, and authorities, there remains a disconnect between expected goals and implementation.
由于胆管癌诊疗指南研究领域取得的突破，胆管癌治疗显著提高了诊断效率和生存预后。我们比较了最新更新的临床实践指南和共识，以便根据各国现有的诊断和治疗设备提供建议。经过系统综述，我们发现这些指南和共识在指南的起草组织或团体、指南的方法、适用性、内容和最新更新以及诊断和治疗算法方面既有相似之处，也有不同之处。这些差异可能归因于多种病因因素、高危患者、卫生资源、医疗技术、治疗选择和收入水平。此外，虽然完全采用指南可能会使医生、患者和当局受益，但预期目标与实施之间仍存在脱节。
